ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,914Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 36

$647K Total Retail Price of All Prescriptions

Rank: 12 out of 36

433 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 433 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 433 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 10,321 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
AMLODIPINE BESYLATE 605 555 1 1
LEVOTHYROXINE SODIUM 449 423 2 4
SIMVASTATIN 422 382 3 2
OMEPRAZOLE 362 324 4 6
HYDROCHLOROTHIAZIDE 305 262 5 9
ATORVASTATIN CALCIUM 295 272 6 22
METFORMIN HCL 267 208 7 11
METOPROLOL SUCCINATE 266 249 8 18
CITALOPRAM HBR 255 218 9 16
HYDROCODONE-ACETAMINOPHEN 234 187 S3 10 7
LOSARTAN POTASSIUM 229 196 11 23
FUROSEMIDE 201 177 12 5
PANTOPRAZOLE SODIUM 183 179 13 35
WARFARIN SODIUM 182 162 14 17
METOPROLOL TARTRATE 180 175 15 8
CRESTOR 179 150 16 36
ATENOLOL 172 167 17 27
LISINOPRIL 169 113 18 3
CEFUROXIME 145 136 19 105
NEXIUM 144 86 20 26
PREDNISONE 139 134 21 59
ISOSORBIDE MONONITRATE ER 130 130 22 42
ESCITALOPRAM OXALATE 124 105 23 47
ZOLPIDEM TARTRATE 122 66 24 24
POTASSIUM CHLORIDE 120 113 25 15
GABAPENTIN 119 102 26 10
FAMOTIDINE 117 117 27 30
NAMENDA 113 113 28 13
CLOPIDOGREL 112 112 29 33
RANITIDINE HCL 109 97 30 25
SERTRALINE HCL 104 84 31 19
SYNTHROID 104 85 31 68
BENICAR 104 95 31 120
CARVEDILOL 103 91 34 20
JANUVIA 98 97 35 55
AMITRIPTYLINE HCL 86 80 R 36 91
PLAVIX 85 85 37 52
VENLAFAXINE HCL ER 83 81 38 87
TRAMADOL HCL 83 56 38 14
CYMBALTA 82 43 40 48
LOSARTAN-HYDROCHLOROTHIAZIDE 75 69 41 63
TAMSULOSIN HCL 73 50 42 41
TRICOR 72 62 43 113
LIPITOR 72 58 43 100
CELEBREX 68 52 45 118
DONEPEZIL HCL 66 66 46 12
KLOR-CON 10 66 49 46 75
QUETIAPINE FUMARATE 65 56 48 37
LEXAPRO 65 61 48 135
DIOVAN 63 58 50 40
DOXAZOSIN MESYLATE 62 59 51 78
LANTUS 61 44 52 38
ROPINIROLE HCL 61 46 52 80
LISINOPRIL-HYDROCHLOROTHIAZIDE 61 35 52 49
PAROXETINE HCL 61 58 52 57
KLOR-CON M10 59 51 56 103
NIASPAN 59 47 56 145
SYMBICORT 57 44 58 122
NAPROXEN 56 56 59 79
PRAVASTATIN SODIUM 55 42 60 21
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 30, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.